Mitigating Risks and Attracting Rewards – How To Capitalize and Spot Innovation

Director Paul A. Ainsworth will moderate the panel “Mitigating Risks and Attracting Rewards – How To Capitalize and Spot Innovation” during the biotech track of the LSX World Congress 2023 on May 4, 2023. This event is hosted by LSX in London, UK from May 3-4, 2023.

The LSX World Congress brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments – all geared at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes.

Panel Overview

The past three years saw venture capitalists invest $52 billion into therapeutic-based biotech companies globally, with $35 billion of this going into startups with transformative platform technologies. This session explores how investors evaluate “the next big thing” and what biotech founders with novel or innovative technologies can do to put their best feet forwards.

• How investors evaluate risk, particularly when looking at new fields or technologies
• Appetite for investing in novel biotechnologies vs platforms
• How investors keep on top of new ideas and what grabs their interest (and what turns them off)
• How to identify “must have” science early on
• Building an effective founding team including crucial roles and qualities
• Where to deploy capital at the outset and why